Hepatocellular carcinoma
Conditions
Interventions
Observation group:None
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Subjects voluntarily joined the study, signed the informed consent form, had good compliance, and cooperated with follow-up; 2. Age>=18 years old (calculated on the day of signing informed consent), both male and female; 3. Have at least one measurable lesion according to RECIST1.1 criteria; 4. ECOG physical state score 2 points, ASA score 3 points; 5. No other malignant tumors have occurred within five years.
Exclusion criteria
Exclusion criteria: 1. The examination showed that fibrolamellar HCC, sarcomatoid HCC or mixed cholangiocarcinoma. Liver transplant status or history of active autoimmune disease; 2. The patient has other serious comorbidities: such as severe cardiopulmonary diseases, cardiac function below clinical grade 2, pulmonary sensibilities, moderate to severe COPD, chronic bronchiitis, etc., severe diabetes and/or renal insufficiency, severe malnutrition, etc.; 3. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ITGB2 expression level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival (PFS);Overall Survival (OS); | — |
Countries
China
Contacts
Public ContactHuang Xiaolun
Sichuan Cancer Hospital
Outcome results
None listed